| Long-term complication after LM bifurcation treatment. | |
| | |
MedLine Citation:
|
PMID: 20146313 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Two months after left anterior descending (LAD) artery and left circumflex (LCx) artery bare metal stent implantation, a proliferative subocclusive in-stent restenosis in LCx coronary with severe LM coronary (LM) involvement developed. The present clinical case describes a simplified strategy for unprotected LM percutaneous coronary intervention using two bioabsorbable biolimus-eluting stents without involvement of the LAD coronary using an "L" technique. |
| | |
Authors:
|
Marco V Wainstein; Jorge P Ribeiro |
Related Documents
:
|
16908773 - Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phospho... 12479913 - Complete vascular healing and sustained suppression of neointimal thickening after loca... 12197013 - A detailed anatomical description of the subvastus region and its clinical relevance fo... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions Volume: 75 ISSN: 1522-726X ISO Abbreviation: Catheter Cardiovasc Interv Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-06-02 Completed Date: 2010-09-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100884139 Medline TA: Catheter Cardiovasc Interv Country: United States |
Other Details:
|
Languages: eng Pagination: 1045-9 Citation Subset: IM |
Affiliation:
|
Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. mvwainstein@uol.com.br |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary
/
adverse effects*,
instrumentation Cardiovascular Agents / administration & dosage Coronary Angiography Coronary Restenosis / etiology*, radiography, therapy Coronary Stenosis / therapy* Drug-Eluting Stents Humans Male Metals Middle Aged Prosthesis Design Sirolimus / administration & dosage, analogs & derivatives Stents Time Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Biolimus A9; 0/Cardiovascular Agents; 0/Metals; 53123-88-9/Sirolimus |
| Comments/Corrections | |
Comment In:
|
Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1050
[PMID:
20517967
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty.
Next Document: Cardiovascular computed tomographic angiography evaluation following unsuccessful invasive angiograp...